Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review

被引:12
作者
Golonko, Aleksandra [1 ,2 ]
Pienkowski, Tomasz [2 ]
Swislocka, Renata [3 ]
Orzechowska, Sylwia [4 ]
Marszalek, Krystian [1 ]
Szczerbinski, Lukasz [2 ]
Swiergiel, Artur Hugo [1 ,5 ]
Lewandowski, Wlodzimierz [1 ,3 ]
机构
[1] State Res Inst, Prof Waclaw Dabrowski Inst Agr & Food Biotechnol, Rakowiecka 36, PL-02532 Warsaw, Poland
[2] Med Univ Bialystok, Clin Res Ctr, M Sklodowskiej Curie 24a, PL-15276 Bialystok, Poland
[3] Bialystok Tech Univ, Dept Chem Biol & Biotechnol, Wiejska 45, PL-15351 Bialystok, Poland
[4] Jagiellonian Univ, Fac Chem, Gronostajowa 2, PL-30387 Krakow, Poland
[5] Univ Gdansk, Fac Biol, Dept Anim & Human Physiol, W Stwosza 59, PL-80308 Gdansk, Poland
关键词
BREAST-CANCER; VITAMIN-C; T-CELLS; CALORIC RESTRICTION; ANTITUMOR IMMUNITY; MILK PROTEIN; RECEPTOR; EFFICACY; PD-L1; SUPPLEMENTATION;
D O I
10.1038/s41419-024-06641-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Immunotherapy is emerging as a promising avenue in oncology, gaining increasing importance and offering substantial advantages when compared to chemotherapy or radiotherapy. However, in the context of immunotherapy, there is the potential for the immune system to either support or hinder the administered treatment. This review encompasses recent and pivotal studies that assess the influence of dietary elements, including vitamins, fatty acids, nutrients, small dietary molecules, dietary patterns, and caloric restriction, on the ability to modulate immune responses. Furthermore, the article underscores how these dietary factors have the potential to modify and enhance the effectiveness of anticancer immunotherapy. It emphasizes the necessity for additional research to comprehend the underlying mechanisms for optimizing the efficacy of anticancer therapy and defining dietary strategies that may reduce cancer-related morbidity and mortality. Persistent investigation in this field holds significant promise for improving cancer treatment outcomes and maximizing the benefits of immunotherapy.
引用
收藏
页数:16
相关论文
共 181 条
  • [21] Vitamin D Receptor Inhibits Nuclear Factor κB Activation by Interacting with IκB Kinase β Protein
    Chen, Yunzi
    Zhang, Jing
    Ge, Xin
    Du, Jie
    Deb, Dilip K.
    Li, Yan Chun
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (27) : 19450 - 19458
  • [22] The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story
    Cheng, Hongyu
    Guan, Xiong
    Chen, Dekun
    Ma, Wentao
    [J]. MICROORGANISMS, 2019, 7 (12)
  • [23] Whey Protein Concentrate Renders MDA-MB-231 Cells Sensitive to Rapamycin by Altering Cellular Redox State and Activating GSK3β/mTOR Signaling
    Cheng, Shih-Hsuan
    Tseng, Yang-Ming
    Wu, Szu-Hsien
    Tsai, Shih-Meng
    Tsai, Li-Yu
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [24] Clay TM, 1999, J IMMUNOL, V163, P507
  • [25] Cytokines in the Treatment of Cancer
    Conlon, Kevin C.
    Miljkovic, Milos D.
    Waldmann, Thomas A.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (01) : 6 - 21
  • [26] Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
    Coombs, Melanie R. Power
    Harrison, Megan E.
    Hoskin, David W.
    [J]. CANCER LETTERS, 2016, 380 (02) : 424 - 433
  • [27] A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
    Cortellini, Alessio
    Bersanelli, Melissa
    Buti, Sebastiano
    Cannita, Katia
    Santini, Daniele
    Perrone, Fabiana
    Giusti, Raffaele
    Tiseo, Marcello
    Michiara, Maria
    Di Marino, Pietro
    Tinari, Nicola
    De Tursi, Michele
    Zoratto, Federica
    Veltri, Enzo
    Marconcini, Riccardo
    Malorgio, Francesco
    Russano, Marco
    Anesi, Cecilia
    Zeppola, Tea
    Filetti, Marco
    Marchetti, Paolo
    Botticelli, Andrea
    Cappellini, Gian Carlo Antonini
    De Galitiis, Federica
    Vitale, Maria Giuseppa
    Rastelli, Francesca
    Pergolesi, Federica
    Berardi, Rossana
    Rinaldi, Silvia
    Tudini, Marianna
    Silva, Rosa Rita
    Pireddu, Annagrazia
    Atzori, Francesco
    Chiari, Rita
    Ricciuti, Biagio
    De Giglio, Andrea
    Iacono, Daniela
    Gelibter, Alain
    Occhipinti, Mario Alberto
    Parisi, Alessandro
    Porzio, Giampiero
    Fargnoli, Maria Concetta
    Ascierto, Paolo Antonio
    Ficorella, Corrado
    Natoli, Clara
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Cusato, Jessica
    Genova, Carlo
    Tomasello, Cristina
    Carrega, Paolo
    Ottonello, Selene
    Pietra, Gabriella
    Mingari, Maria Cristina
    Cossu, Irene
    Rijavec, Erika
    Leggieri, Anna
    Di Perri, Giovanni
    Dal Bello, Maria Giovanna
    Coco, Simona
    Boccardo, Simona
    Ferlazzo, Guido
    Grossi, Francesco
    D'Avolio, Antonio
    [J]. CANCERS, 2019, 11 (01):
  • [29] Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis
    Cutone, Antimo
    Colella, Barbara
    Pagliaro, Andrea
    Rosa, Luigi
    Lepanto, Maria Stefania
    di Patti, Maria Carmela Bonaccorsi
    Valenti, Piera
    Di Bartolomeo, Sabrina
    Musci, Giovanni
    [J]. CELLULAR SIGNALLING, 2020, 65
  • [30] STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
    Cuyas, Elisabet
    Perez-Sanchez, Almudena
    Micol, Vicente
    Menendez, Javier A.
    Bosch-Barrera, Joaquim
    [J]. CELL CYCLE, 2016, 15 (24) : 3413 - 3418